Literature DB >> 1711956

Gastric cytoprotection. What does it really mean for the prescriber?

M Guslandi1.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1711956     DOI: 10.2165/00003495-199141040-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  72 in total

1.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

Review 2.  Combined therapies for upper gastrointestinal disorders--any advantage?

Authors:  M Guslandi
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

3.  Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing.

Authors:  J Y Kang; D W Piper
Journal:  Digestion       Date:  1982       Impact factor: 3.216

4.  Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.

Authors:  F I Lee; I M Samloff; M Hardman
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

Review 5.  Implications of sucralfate-induced ulcer healing and relapse.

Authors:  S K Lam
Journal:  Am J Med       Date:  1989-06-09       Impact factor: 4.965

6.  Sucralfate and ranitidine in the treatment of acute duodenal ulcer. Healing and relapse. Ulcer Study Group.

Authors:  H R Koelz; F Halter
Journal:  Am J Med       Date:  1989-06-09       Impact factor: 4.965

7.  Comparison of tri-potassium di-citrato bismuthate (TDB) with ranitidine in healing and relapse of gastric ulcer.

Authors:  F Cipollini; F Altilia
Journal:  Br J Clin Pract       Date:  1987-04

8.  Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.

Authors:  I Hamilton; H J O'Connor; N C Wood; I Bradbury; A T Axon
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

9.  Assessment of the 'mucus-bicarbonate' barrier in the stomach of patients with chronic gastric disorders.

Authors:  M Guslandi; E Ballarin
Journal:  Clin Chim Acta       Date:  1984-12-29       Impact factor: 3.786

Review 10.  Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.

Authors:  K D Rainsford
Journal:  Scand J Gastroenterol Suppl       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.